Anti-CD22 (Epratuzumab)-CL2E-SN-38 ADC

CAT:

708-ADC-W-334

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

Description: This ADC product is comprised of an a Epratuzumab conjugated via a CL2E linker to a SN-38. The SN-38 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. The SN-38 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, SN-38 binds to DNA, causes DNA damage.
CAS Number: 9007-83-4
Format: Solution
Shipping Conditions: Ice Packs
Storage Conditions: -20°C

Cat	Name
ADC-W-334	Anti-CD22 (Epratuzumab)-CL2E-SN-38 ADC
ADC-W-333	Anti-CD22 (Epratuzumab)-CL2A-SN-38 ADC
ADC-W-580	Anti-TACSTD2 (hRS7)-CL2E-SN-38 ADC
ADC-W-326	Anti-MS4A1 (Veltuzumab)-CL2E-SN-38 ADC
ADC-W-577	Anti-CD74 (clone hLL1)-CL2E-SN-38 ADC
ADC-W-093	Anti-CD22 (hLL2)-SN-38 ADC
ADC-W-2527	Anti-CD22 (Epratuzumab)-SMCC-DM1 ADC
ADC-W-2528	Anti-CD22 (Epratuzumab)-SPDB-DM4 ADC
ADC-W-336	Anti-CD22 (Epratuzumab)-MCC-DM1 ADC
ADC-W-335	Anti-CD22 (Epratuzumab)-Mc-MMAF ADC

Cat	Name
MBS488271-01	Anti-CD22 [hL22 (Epratuzumab)]
MBS488272-01	Anti-CD22 [hL22 (Epratuzumab)]
MBS488272-02	Anti-CD22 [hL22 (Epratuzumab)]
MBS488271-02	Anti-CD22 [hL22 (Epratuzumab)]
A1445-200	Anti-CD22 (Epratuzumab), Human IgG1 Antibody
YR1021-02	Anti-Human CD22 Recombinant Antibody (Epratuzumab)
F1187-.1	Anti-Siglec-2/CD22 Antibody (Epratuzumab)
YR1021-01	Anti-Human CD22 Recombinant Antibody (Epratuzumab)
F1187-1	Anti-Siglec-2/CD22 Antibody (Epratuzumab)
MBS9247340-02	Anti-Siglec-2/CD22 Reference Antibody (epratuzumab)